GlassScriptPhysician profile
Christina Burrage
NPI 1700370939
$714.46
in general payments reported to CMS, 2019-2025
10 companies · $415 in 2025
The $415 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.91 · 2023: $17.30 · 2024: $257 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $271.57 | 2024-2025 | Impella |
| Atricure, INC. | $122.15 | 2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Inspire Medical Systems, INC. | $74.00 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $55.33 | 2021-2025 | Tezspire, Airsupra |
| Merck Sharp & Dohme LLC | $47.68 | 2023-2025 | Zerbaxa |
| 3b Medical, INC. | $45.49 | 2024-2025 | Luna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.87 | 2024-2025 | Ofev, Jardiance |
| Ambu INC. | $34.09 | 2025 | |
| Mallinckrodt Hospital Products INC. | $16.14 | 2024 | Acthar |
| Electromed, INC. | $13.14 | 2024 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Burrage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.